Show/Hide Menu
Hide/Show Apps
anonymousUser
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Videos
Videos
Thesis submission
Thesis submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Contact us
Contact us
Design, synthesis and biological evaluation of novel 1,3-diarylpyrazoles as cyclooxygenase inhibitors, antiplatelet and anticancer agents.
Date
2018-04-06
Author
Inceler, Nazan
ÖZKAN, YEŞİM
Turan, Nilufer Nermin
Kahraman, Deniz Cansen
Atalay, Rengül
BAYTAŞ, Sultan
Metadata
Show full item record
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
Item Usage Stats
10
views
0
downloads
Cite This
With the aim of achieving new compounds possessing both anti-inflammatory and antiplatelet activities, we synthesized (E)-3-[3-(pyridin-3/4-yl)-1-(phenyl/sulfonylmethylphenyl)-1H-pyrazol-4-yl]acrylamides, and evaluated their COX-1 and COX-2 inhibitory and antiplatelet activities. Since COX-2 inhibitory and antiplatelet compounds have anticancer potential, we also screened their antiproliferative effects against three human cancer cell lines. Compounds 5n, 5p, 5s, 10d, 10g and 10i were determined as dual COX-2 inhibitor/antiplatelet compounds. Compound 10h appeared to be a compound that exhibited antiplatelet activity without inhibiting the COX enzyme. Compounds 5h, 10a and 10i were the most effective derivatives which displayed antiproliferative activity against Huh7, MCF7 and HCT116 cells. Particularly, compound 10i, as the compound exhibiting the highest cytotoxic, antiplatelet and COX-2 inhibitory activity, was remarkable.
Subject Keywords
Selective cox-2 inhibitors
,
Cardiovascular risk
,
Prostaglandin endoperoxides
,
Antiinflammatory activities
,
Breast-cancer
,
Derivatives
,
Thromboxane
,
Expression
,
Carcinoma
,
Prostacyclin
URI
https://hdl.handle.net/11511/32359
Journal
MedChemComm
DOI
https://doi.org/10.1039/c8md00022k
Collections
Graduate School of Informatics, Article
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
N. Inceler, Y. ÖZKAN, N. N. Turan, D. C. Kahraman, R. Atalay, and S. BAYTAŞ, “Design, synthesis and biological evaluation of novel 1,3-diarylpyrazoles as cyclooxygenase inhibitors, antiplatelet and anticancer agents.,”
MedChemComm
, vol. 9, no. 5, pp. 795–811, 2018, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/32359.